Emmes partners with Miimansa AI to accelerate adoption of Generative AI in clinical research
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data
The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
The academy has secured partnerships with 15 esteemed hospitals
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
Subscribe To Our Newsletter & Stay Updated